The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
Open accessAbstract
Small cell lung cancer (SCLC) is one of the most lethal human malignancies. To investigate the cellular origin(s) of this cancer, we assessed the effect of Trp53 and Rb1 inactivation in distinct cell types in the adult lung using adenoviral vectors that target Cre recombinase to Clara, neuroendocrine (NE), and alveolar type 2 (SPC-expressing) cells. Using these cell type-restricted Adeno-Cre viruses, we show that loss of Trp53 and Rb1 can efficiently transform NE and SPC-expressing cells leading to SCLC, albeit SPC-expressing cells at a lesser efficiency. In contrast, Clara cells were largely resistant to transformation. The results indicate that although NE cells serve as the predominant cell of origin of SCLC a subset of SPC-expressing cells are also endowed with this ability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, there is preclinical evidence that type II alveolar cells have the potential to differentiate into SCLC after the targeted disruption of Tp53 and Rb1.35”
From Mechanisms of resistance to EGFR-targeted drugs: lung cancer (2016) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D. G., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,229
Basal cells as stem cells of the mouse trachea and human airway epithelium
Rock, J. R., Onaitis, M. W., Rawlins, E. L., Lu, Y., Clark, C. P., Xue, Y., Randell, S. H., & Hogan, B. L. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906850106 · Cited by 1,591
Visvader, J. E. (2011) · Nature · doi:10.1038/nature09781 · Cited by 1,524
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Ward, E., Wu, X., Eheman, C. R., Anderson, R. N., Ajani, U. A., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 961
Rawlins, E. L., Okubo, T., Xue, Y., Brass, D. M., Auten, R. L., Hasegawa, H., Wang, F., & Hogan, B. L. M. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.002 · Cited by 872
Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling
Rock, J. R., Randell, S. H., & Hogan, B. L. M. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.006031 · Cited by 765
A luminal epithelial stem cell that is a cell of origin for prostate cancer
Wang, X., Julio, M. K., Economides, K. D., Walker, D., Yu, H., Halili, M. V., Hu, Y.-P., Price, S. M., Abate-Shen, C. T., & Shen, M. M. (2009) · Nature · doi:10.1038/nature08361 · Cited by 753
Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed · Cited by 713
Flagged first, then by citations
2 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 538
Management of Small Cell Lung Cancer
Altan, M., & Chiang, A. C. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000148 · Cited by 36
Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation
Wang, Y., Tan, X., Tang, Y., Zhang, C., Xu, J., Zhou, J. H., Cheng, X., Hou, N., Liu, W., Yang, G., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0161 · Cited by 33
Epithelial cell plasticity: breaking boundaries and changing landscapes
Tata, A., Chow, R. D.-W., & Tata, P. R. (2021) · EMBO Reports · doi:10.15252/embr.202051921 · Cited by 32
Yang, Y., & Fan, S. (2024) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2023.10.005 · Cited by 33
MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat
Chen, J., Guanizo, A. C., Jayasekara, W. S. N., Inampudi, C., Luong, Q., Garama, D. J., Alamgeer, M., Thakur, N., DeVeer, M., Ganju, V., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02678-1 · Cited by 33
Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics
Das, S., & Samaddar, S. (2025) · Cancers · doi:10.3390/cancers17020255 · Cited by 32
Keeping it together: Pulmonary alveoli are maintained by a hierarchy of cellular programs
Logan, C. Y., & Desai, T. (2015) · BioEssays · doi:10.1002/bies.201500031 · Cited by 32
Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
Chen, F., Liu, J., Flight, R. M., Naughton, K. J., Lukyanchuk, A., Edgin, A. R., Song, X., Zhang, H., Wong, K., Moseley, H., et al. (2021) · Advanced Science · doi:10.1002/advs.202101999 · Cited by 30
Chen, J., Guanizo, A. C., Luong, Q., Jayasekara, W. S. N., Jayasinghe, D., Inampudi, C., Szczepny, A., Garama, D. J., Russell, P. A., Ganju, V., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02070-3 · Cited by 31
Li, Y., & Linnoila, R. I. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0027oc · Cited by 31
Cross-Species Transcriptome Profiling Identifies New Alveolar Epithelial Type I Cell–Specific Genes
Marconett, C. N., Zhou, B., Sunohara, M., Pouldar, T. M., Wang, H., Liu, Y., Rieger, M. E., Tran, E., Flodby, P., Siegmund, K. D., et al. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0071oc · Cited by 31
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation
Qin, Z., Yue, M., Tang, S., Wu, F., Sun, H., Li, Y., Zhang, Y., Izumi, H., Huang, H., Wang, W., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20232028 · Cited by 29
Li, Y., Xie, T., Wang, S., Yang, L., Hao, X., Wang, Y., Hu, X., Wang, L., Li, J., Ying, J., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01981-3 · Cited by 29
Du, J., Li, Y., Wang, L., Zhou, Y., Shen, Y., Xu, F., & Chen, Y. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.037 · Cited by 29
Lineage Plasticity in Cancer: The Tale of a Skin-Walker
Thankamony, A. P., Subbalakshmi, A. R., Jolly, M. K., & Nair, R. (2021) · Cancers · doi:10.3390/cancers13143602 · Cited by 28
van Miltenburg, M. H., & Jonkers, J. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.01.004 · Cited by 32
Histologic transformation in lung cancer: when one door shuts, another opens
Sato, Y., Saito, G., & Fujimoto, D. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221130503 · Cited by 27
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity
Banerjee, A., Vathiotis, I. A., Halder, D., Sen, U., Wang, X., Shields, M. D., Veluswamy, R. R., Syrigos, K., Hirsch, F. R., & Sen, T. (2025) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.06.012 · Cited by 30
Voigt, E. M., Wallenburg, M., Wollenzien, H., Thompson, E., Kumar, K., Feiner, J., McNally, M., Friesen, H. J., Mukherjee, M., Tecleab, Y. A., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-1006 · Cited by 28
Cell cycle duration determines oncogenic transformation capacity
Chen, D., Lü, S., Huang, K., Pearson, J. D., Pacal, M., Peidis, P., McCurdy, S. R., Yu, T., Sangwan, M., Nguyen, A., et al. (2025) · Nature · doi:10.1038/s41586-025-08935-x · Cited by 32
Park, S., Rong, L., Owczarek, T. B., Bernardo, M. D., Shoulson, R. L., Chua, C. W., Kim, J. Y., Lankarani, A., Chakrapani, P., Syed, T., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1254 · Cited by 26
Retinoblastoma Protein Paralogs and Tumor Suppression
Flores, M., & Goodrich, D. W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.818719 · Cited by 28
Harnessing preclinical models for the interrogation of ovarian cancer
Qin, T., Fan, J., Lu, F., Zhang, L., Liu, C., Xiong, Q., Zhao, Y., Chen, G., & Sun, C. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02486-z · Cited by 30
Cell adhesion and polarity in squamous cell carcinoma of the lung
Bonastre, E., Brambilla, E. M., & Sánchez‐Céspedes, M. (2016) · The Journal of Pathology · doi:10.1002/path.4686 · Cited by 26
Schnorbusch, K., Lembrechts, R., Pintelon, I., Timmermans, J., Brouns, I., & Adriaensen, D. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1093-x · Cited by 26
Self-citationPreclinical Models for the Study of Lung Cancer Pathogenesis and Therapy DevelopmentPreprint
Estape, A. A., Foggetti, G., Starrett, J. H., Nguyen, D. X., & Politi, K. A. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037820 · Cited by 23
Thakur, A., Mei, S., Zhang, N., Zhang, K., Taslakjian, B., Lian, J., Wu, S., Chen, B., Solway, J., & Chen, H. J. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1438188 · Cited by 27
Närhi, K. M., Nagaraj, A. S., Parri, E., Turkki, R., van Duijn, P. W., Hemmes, A., Lahtela, J., Uotinen, V., Mäyränpää, M. I., Salmenkivi, K., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5059 · Cited by 23
Xu, J., Xu, L., Wang, B., Kong, W., Chen, Y., & Yu, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.766148 · Cited by 25
Chen, W., Huang, A.-F., Huang, S., Ho, C., Chang, Y., & Chan, J. Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11132 · Cited by 25
Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett’s Stemming from SPEM
Jin, R. U., & Mills, J. C. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5150-0 · Cited by 25
Mak, D. W.-S., Su, L., & Minchom, A. R. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.037 · Cited by 24
Zhang, L., Zhu, X., Liu, C., Zhang, B., Zheng, J., Singh, P. K., Bshara, W., Wang, J., Gomez, E. C., Zhang, X., et al. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.11.019 · Cited by 24
Tao, X., Li, Y., Fan, S., Wu, L., Xin, J., Su, Y., Xian, X., Huang, Y., Huang, R., Fang, W., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02560-6 · Cited by 24
A review of recent advances in the novel therapeutic targets and immunotherapy for lung cancer
Khadela, A. D., Postwala, H. I., Rana, D. K., Dave, H., Ranch, K. M., & Boddu, S. H. S. (2023) · Medical Oncology · doi:10.1007/s12032-023-02005-w · Cited by 24
Yoshimoto, T., Motoi, N., Yamamoto, N., Nagano, H., Ushijima, M., Matsuura, M., Okumura, S., Yamaguchi, T., Fukayama, M., & Ishikawa, Y. (2017) · Neuroendocrinology · doi:10.1159/000461582 · Cited by 24
The Importance of Detailed Epigenomic Profiling of Different Cell Types within Organs
Stueve, T. R., Marconett, C. N., Zhou, B., Borok, Z., & Laird‐Offringa, I. A. (2016) · Epigenomics · doi:10.2217/epi-2016-0005 · Cited by 24
Verckist, L., Pintelon, I., Timmermans, J., Brouns, I., & Adriaensen, D. (2018) · Respiratory Research · doi:10.1186/s12931-018-0915-8 · Cited by 23
Self-citationHao, L., Chen, H., Wang, L., Zhou, H., Zhang, Z., Han, J., Hou, J., Zhu, Y., Zhang, H., & Wang, Q. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.14832 · Cited by 23
Persson, M. M., Johansson, M., Monsef, N., Planck, M., Beckman, S., Seckl, M. J., Rönnstrand, L., Påhlman, S., & Pettersson, H. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.014 · Cited by 23
Cyclin‐dependent kinase 7 inhibitor THZ1 in cancer therapy
Li, B., Wang, B., Zhu, C., Tang, D., Pang, J., Zhao, J., Sun, C., Qiu, M., & Qian, Z. (2019) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.08.006 · Cited by 23
MoS2@Au as Label for Sensitive Sandwich-Type Immunoassay of Neuron-Specific Enolase
Wang, Y., Wang, H., Bai, Y., Zhao, G., Zhang, N., Zhang, Y., Wang, Y., & Chi, H. (2023) · Chemosensors · doi:10.3390/chemosensors11060349 · Cited by 22
Comprehensive genomic profiling of combined small cell lung cancer
written on behalf of the AME Lung Cancer Collaborative Group, Zhang, J., Zhang, L., Luo, J., Tao, G., Fan, P., Sun, L., Hou, L., Li, J., Yu, H., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1099 · Cited by 22
Endocrine and paracrine characteristics of neuroendocrine prostate cancer
Arman, T., & Nelson, P. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1012005 · Cited by 23
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma
Ooki, A., Osumi, H., Fukuda, K., & Yamaguchi, K. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10121-2 · Cited by 24
Versatile and enhanced tumour modelling in mice via somatic cell transduction
Rodríguez, E., Mannion, L., D’Santos, P., Griffiths, M. H. G., Arends, M. J., Brindle, K. M., & Lyons, S. K. (2013) · The Journal of Pathology · doi:10.1002/path.4313 · Cited by 22
Investigating pulmonary neuroendocrine cells in human respiratory diseases with airway models
Candeli, N., & Dayton, T. L. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050620 · Cited by 21
Prognostic significance of procalcitonin in small cell lung cancer
Ichikawa, K., Watanabe, S., Miura, S., Ohtsubo, A., Shoji, S., Nozaki, K., Tanaka, T., Saida, Y., Kondo, R., Hokari, S., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-838 · Cited by 21
Yu, G., Chen, Y., Hu, Y., Zhou, Y., Ding, X., & Zhou, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1010639 · Cited by 25
Horie, M., Miyashita, N., Mattsson, J. S. M., Mikami, Y., Sandelin, M., Brunnström, H., Micke, P., Nagase, T., & Saito, A. (2018) · The Journal of Pathology · doi:10.1002/path.5109 · Cited by 21
Definitive evidence for Club cells as progenitors for mutant Kras/Trp53‐deficient lung cancer
Rosigkeit, S., Kruchem, M., Thies, D., Kreft, A., Eichler, E., Boegel, S., Jansky, S., Siegl, D., Kaps, L., Pickert, G., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33756 · Cited by 20
Duan, J., Guan, X., Yang, H., Mei, W.-X., Chen, P., Tao, J., Li, Q., & Zhou, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108211 · Cited by 21
Koba, H., Kimura, H., Yoneda, T., Ogawa, N., Tanimura, K., Tambo, Y., Sone, T., Hosomichi, K., Tajima, A., & Kasahara, K. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-536 · Cited by 20
Significantly mutated genes and regulatory pathways in SCLC—a meta-analysis
Sundaresan, V., Lin, V. T. G., Liang, F., Kaye, F. J., Kawabata‐Iwakawa, R., Shiraishi, K., Kohno, T., Yokota, J., & Zhou, L. J. (2017) · Cancer Genetics · doi:10.1016/j.cancergen.2017.05.003 · Cited by 20
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
Lin, C.-A., Yu, S., Chen, H., Chen, H., Lin, S.-U., Chang, C., Yu, C., Yang, P., & Ho, C. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.11.021 · Cited by 20
Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer
Nicoś, M., & Krawczyk, P. A. (2022) · Cancers · doi:10.3390/cancers14071813 · Cited by 21
Ni, Z., Wang, X., Zhang, T., Li, L., & Li, J. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5833 · Cited by 19
Plasma signals of lung tumor promotion for molecular cancer prevention
Pandya, T., Zagorulya, M., Leung, M. M., Augustine, M., Liu, L., Leppä, A., Baruchel, U., Ng, S. W., Klockner, T., Mugabo, M., et al. (2026) · Cell · doi:10.1016/j.cell.2026.05.005 · Cited by 22
CGRP: A New Endogenous Cell Stemness Maintenance Molecule
Lv, X., Chen, Q., Zhang, S., Gao, F., & Liu, Q. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4107433 · Cited by 18
Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies
Kohno, S., Kitajima, S., Sasaki, N., & Takahashi, C. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i4.170 · Cited by 18
Development of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation
Shim, J., Choi, J., Park, M.-H., Kim, H., Kim, J.-H., Kim, S., Hong, D., Kim, S., Lee, J. E., Kim, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19424 · Cited by 18
Shao, Y., & Zhong, D. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1211-1 · Cited by 18
Airway stem cells and lung cancer
Succony, L., & Janes, S. M. (2014) · QJM · doi:10.1093/qjmed/hcu040 · Cited by 17
FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium
Best, S. A., Harapas, C. R., Kersbergen, A. J., Rathi, V., Asselin-Labat, M.-L., & Sutherland, K. D. (2018) · Oncogene · doi:10.1038/s41388-018-0399-5 · Cited by 17
Self-citationLi, H., Zhong, R., He, C., Tang, C., Cui, H., Li, R., Liu, Y., Lan, S., & Cheng, Y. (2022) · Oncology Reports · doi:10.3892/or.2022.8333 · Cited by 17
Hartmann, G. G., & Sage, J. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0265 · Cited by 17
TNF-α-induced CXCL8 production by A549 cells: Involvement of the non-neuronal cholinergic system
Xu, Z., Devillier, P., Xu, G.-N., Qi, H. Y., Zhu, L., Zhou, W., Hou, L.-N., Tang, Y., Yang, K., Yu, Z., et al. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.016 · Cited by 17
Verckist, L., Lembrechts, R., Thys, S., Pintelon, I., Timmermans, J., Brouns, I., & Adriaensen, D. (2017) · Respiratory Research · doi:10.1186/s12931-017-0571-4 · Cited by 17
Self-citationBai, X., Jiang, X., Liu, Y., Wang, Y., Jiang, X., Song, G. Y., Qiu, H., & Zhang, Q. (2021) · PubMed Central · Cited by 17
Kelenis, D. P., Rodarte, K. E., Kollipara, R. K., Pozo, K., Choudhuri, S. P., Spainhower, K. B., Wait, S. J., Stastny, V., Oliver, T. G., & Johnson, J. E. B. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3713 · Cited by 17
Toyokawa, G., Bersani, F., Bironzo, P., Picca, F., Tabbò, F., Haratake, N., Takenaka, T., Seto, T., Yoshizumi, T., Novello, S., et al. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.103966 · Cited by 18
He, M. Y., Liu, S., Kankanamalage, S. G., Borromeo, M. D., Girard, L., Gazdar, A. F., Minna, J. D., Johnson, J. E. B., & Cobb, M. H. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.01.004 · Cited by 17
Egawa‐Takata, T., Yoshino, K., Hiramatsu, K., Nakagawa, S., Serada, S., Nakajima, A., Endo, H., Kubota, S., Matsuzaki, S., Kobayashi, E., et al. (2018) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001354 · Cited by 17
Fukushima, T., Togasaki, K., Hamamoto, J., Emoto, K., Ebisudani, T., Mitsuishi, A., Sugihara, K., Shinozaki, T., Okada, M., Saito, A., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00945-y · Cited by 16
Hamad, S. H., Montgomery, S. A., Simon, J. M., Bowman, B. M., Spainhower, K. B., Murphy, R. M., Knudsen, E. S., Fenton, S. E., Randell, S. H., Holt, J. R., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02348-0 · Cited by 15
Intracellular signals of lung cancer cells as possible therapeutic targets
Tanaka, K., Kumano, K., & Ueno, H. (2015) · Cancer Science · doi:10.1111/cas.12643 · Cited by 16
Small cell lung cancer transformation during antitumor therapies: A systematic review
Chai, X., Zhang, X., Li, W., & Chai, J. (2021) · Open Medicine · doi:10.1515/med-2021-0321 · Cited by 16
Masawa, M., Sato‐Yazawa, H., Kashiwagi, K., Ishii, J., Miyata-Hiramatsu, C., Iwamoto, M., Kohno, K., Miyazawa, T., Onozaki, M., Noda, S., et al. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.03.007 · Cited by 15
Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
Jin, Y., Chen, Y., Qin, Z., Hu, L., Guo, C., & Ji, H. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023080 · Cited by 16
Ceteci, F., Xu, J., Ceteci, S., Zanucco, E., Thakur, C., & Rapp, U. R. (2011) · Neoplasia · doi:10.1593/neo.11652 · Cited by 16
Rath, B., Plangger, A., & Hamilton, G. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2019.85 · Cited by 15
Lastwika, K. J., Kunihiro, A. G., Solan, J. L., Zhang, Y., Taverne, L. R., Shelley, D., Rho, J.-H., Randolph, T. W., Li, C. I., Grogan, E. L., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add8469 · Cited by 15
Mišković, J., Brekalo, Z., Vukojević, K., Mišković, H. R., Kraljević, D., Todorović, J., & Šoljić, V. (2015) · Acta Histochemica · doi:10.1016/j.acthis.2015.02.002 · Cited by 15
Sen, M., Akeno, N., Reece, A. L., Miller, A. L., Simpson, D. S., & Wikenheiser‐Brokamp, K. A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.5 · Cited by 15
Akeno, N., Reece, A. L., Callahan, M. K., Miller, A. L., Kim, R. G., He, D., Lane, A., Moulton, J. S., & Wikenheiser‐Brokamp, K. A. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0353 · Cited by 15
Protein neddylation as a therapeutic target in pulmonary and extrapulmonary small cell carcinomasPreprint
Norton, J. P., Augert, A., Eastwood, E., Basom, R., Rudin, C. M., & MacPherson, D. P. (2021) · Genes & Development · doi:10.1101/gad.348316.121 · Cited by 16
Wang, G., Wang, Z., Bai, S., Tan, Y., Zhong, W., Sun, G., Liu, Y., Pan, B., Huang, C., Wang, D., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02378-6 · Cited by 15
Wang, H., Gao, N., Wang, L., Yang, F., Liu, B., Hu, X., Zhao, Y., Sha, R., Li, X., & Li, H. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103044 · Cited by 15
Molecular mechanisms of therapy resistance in solid tumors: chasing “moving” targets
Tafe, L. J. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2101-7 · Cited by 14
Ito, M., Miyata, Y., Hirano, S., Kimura, S., Irisuna, F., Ikeda, K., Kushitani, K., Tsutani, Y., Ueda, D., Tsubokawa, N., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22426 · Cited by 15
Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC
Liang, X., Lin, A., Wang, Q., Zhang, J., & Luo, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112909 · Cited by 14
Liu, S., Tao, X., Cao, X., Li, H., & Jin, R. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189413 · Cited by 15
Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer
Wang, A., Han, C., Zhao, H., Zheng, Z., Ye, X., & Shan, R. (2023) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1842_22 · Cited by 14
Llabata, P., Torres-Diz, M., Gómez, A., Tomás-Daza, L., Romero, O. A., Grego‐Bessa, J., Llinàs‐Arias, P., Valencia, A., Esteller, M., Javierre, B. M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024824118 · Cited by 13
Yazawa, T. (2015) · Pathology International · doi:10.1111/pin.12267 · Cited by 13
Lázaro, S., Pérez-Crespo, M., Enguita, A. B., Hernández, P., Martínez‐Palacio, J., Oteo, M., Sage, J., Paramio, J. M., & Santos, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13875 · Cited by 13
Metabolic Phenotypes, Dependencies, and Adaptation in Lung CancerPreprint
DeNicola, G. M., & Shackelford, D. B. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037838 · Cited by 13
Yang, M., Yu, J., Cai, C.-L., & Li, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1029282 · Cited by 12
Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies
Arandhara, A., Bhuyan, P., & Das, B. K. (2025) · Discover Oncology · doi:10.1007/s12672-025-01902-y · Cited by 12
Fragmentation of Small-Cell Lung Cancer Regulatory States in Heterotypic Microenvironments
Schaff, D. L., Singh, S., Kim, K., Sutcliffe, M. D., Park, K.-S., & Janes, K. A. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1036 · Cited by 12
Metadata
- Authors
- Sutherland, K. D., Proost, N., Brouns, I., Adriaensen, D., Song, J.-Y., & Berns, A.
- Affiliations
- The Netherlands Cancer Institute (NL)
- University of Antwerp (BE)
- Corresponding author
- Berns, Anton
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 19
- Issue
- 6
- Pages
- 754-764
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1972570571
- Cited by
- 534
- References
- 48
- Citations by year
- 2026: 22 · 2025: 54 · 2024: 41 · 2023: 48 · 2022: 33 · 2021: 50 · 2020: 40 · 2019: 28 · 2018: 37 · 2017: 33 · 2016: 31 · 2015: 33 · 2014: 20 · 2013: 27 · 2012: 21
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 813 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council (516781)
- Fonds De La Recherche Scientifique - FNRS
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- small cell lung cancer, cell of origin, RB1 inactivation, Clara cells, neuroendocrine cells, alveolar type II cells
- MeSH terms
- Adenoviridae, Animals, Cell Transformation, Neoplastic, Lung, Lung Neoplasms, Tumor Suppressor Protein p53, Retinoblastoma Protein, Integrases, Mice, Neuroendocrine Cells, Small Cell Lung Carcinoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review